GlassScriptPhysician profile
Bayard Wilson
NPI 1508397217
$6,062.49
in general payments reported to CMS, 2019-2025
9 companies · $2,995 in 2025
The $2,995 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.98 · 2021: $88.32 · 2022: $751 · 2023: $815 · 2024: $1,391 · 2025: $2,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,515 · Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,514.94 |
| Food and Beverage | $1,685.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,360.32 | 2025 | Other - Miscellaneous |
| Medtronic, INC. | $1,370.75 | 2021-2025 | Mazor X System, Cd Horizon Spinal System, Catalyft Pl Expandable Interbody System |
| Synthes Gmbh | $959.86 | 2024 | |
| Nuvasive, INC. | $506.43 | 2023 | Reline, Xlif, Simplify Cervical Artificial Disc |
| Boston Scientific Corporation | $285.91 | 2022-2023 | |
| Globus Medical, INC. | $237.19 | 2024-2025 | Captivate, Reline, Modulus |
| Cerapedics INC. | $191.45 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Innovation Technologies INC | $127.60 | 2025 | Irrisept |
| Medtronic USA, INC. | $22.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bayard Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.